Bolt Biotherapeutics Stock Price Prediction
| BOLT Stock | USD 0.50 0.01 1.96% |
Oversold Vs Overbought
42
Oversold | Overbought |
EPS Estimate Next Quarter (0.32) | EPS Estimate Current Year (1.50) | EPS Estimate Next Year (0.89) | Wall Street Target Price 1.75 | EPS Estimate Current Quarter (0.35) |
Using Bolt Biotherapeutics hype-based prediction, you can estimate the value of Bolt Biotherapeutics from the perspective of Bolt Biotherapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Bolt Biotherapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Bolt because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Bolt Biotherapeutics after-hype prediction price | USD 0.5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Bolt |
Bolt Biotherapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Bolt Biotherapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bolt Biotherapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Bolt Biotherapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Bolt Biotherapeutics Estimiated After-Hype Price Volatility
In the context of predicting Bolt Biotherapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bolt Biotherapeutics' historical news coverage. Bolt Biotherapeutics' after-hype downside and upside margins for the prediction period are 0.03 and 3.76, respectively. We have considered Bolt Biotherapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Bolt Biotherapeutics is extremely dangerous at this time. Analysis and calculation of next after-hype price of Bolt Biotherapeutics is based on 3 months time horizon.
Bolt Biotherapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Bolt Biotherapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bolt Biotherapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bolt Biotherapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.44 | 3.28 | 0.00 | 0.00 | 7 Events / Month | 4 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.50 | 0.50 | 0.00 |
|
Bolt Biotherapeutics Hype Timeline
Bolt Biotherapeutics is currently traded for 0.50. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Bolt is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at -0.44%. %. The volatility of related hype on Bolt Biotherapeutics is about 131200.0%, with the expected price after the next announcement by competition of 0.50. About 58.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.27. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bolt Biotherapeutics recorded a loss per share of 1.71. The entity last dividend was issued on the August 29, 2014. The firm had 3:2 split on the January 31, 2008. Given the investment horizon of 90 days the next expected press release will be in about 7 days. Check out Bolt Biotherapeutics Basic Forecasting Models to cross-verify your projections.Bolt Biotherapeutics Related Hype Analysis
Having access to credible news sources related to Bolt Biotherapeutics' direct competition is more important than ever and may enhance your ability to predict Bolt Biotherapeutics' future price movements. Getting to know how Bolt Biotherapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bolt Biotherapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ASMB | Assembly Biosciences | (0.54) | 6 per month | 0.00 | (0.06) | 5.74 | (5.39) | 24.82 | |
| NLTX | Neoleukin Therapeutics | (0.14) | 1 per month | 0.00 | (0.07) | 4.05 | (3.53) | 27.84 | |
| TIL | Instil Bio | 0.76 | 8 per month | 0.00 | (0.03) | 14.68 | (9.64) | 26.56 | |
| CTMX | CytomX Therapeutics | (0.13) | 10 per month | 0.00 | (0.06) | 7.32 | (9.00) | 23.37 | |
| ACHL | Achilles Therapeutics PLC | (0.02) | 2 per month | 1.22 | 0.05 | 2.59 | (2.86) | 19.72 | |
| SPRO | Spero Therapeutics | 0.03 | 9 per month | 0.00 | (0.18) | 5.56 | (4.76) | 17.35 | |
| NUVB | Nuvation Bio | 0.07 | 6 per month | 3.70 | 0.01 | 9.48 | (7.38) | 23.46 | |
| NXTC | NextCure | (0.01) | 7 per month | 0.00 | (0.19) | 6.74 | (7.45) | 24.13 |
Bolt Biotherapeutics Additional Predictive Modules
Most predictive techniques to examine Bolt price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bolt using various technical indicators. When you analyze Bolt charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Bolt Biotherapeutics Predictive Indicators
The successful prediction of Bolt Biotherapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bolt Biotherapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bolt Biotherapeutics based on analysis of Bolt Biotherapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bolt Biotherapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bolt Biotherapeutics's related companies. | 2022 | 2023 | 2024 | 2025 (projected) | Interest Debt Per Share | 0.61 | 0.53 | 0.48 | 0.32 | Revenue Per Share | 0.15 | 0.21 | 0.19 | 0.2 |
Story Coverage note for Bolt Biotherapeutics
The number of cover stories for Bolt Biotherapeutics depends on current market conditions and Bolt Biotherapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bolt Biotherapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bolt Biotherapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Bolt Biotherapeutics Short Properties
Bolt Biotherapeutics' future price predictability will typically decrease when Bolt Biotherapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bolt Biotherapeutics often depends not only on the future outlook of the potential Bolt Biotherapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bolt Biotherapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 37.8 M | |
| Cash And Short Term Investments | 102.2 M |
Additional Tools for Bolt Stock Analysis
When running Bolt Biotherapeutics' price analysis, check to measure Bolt Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bolt Biotherapeutics is operating at the current time. Most of Bolt Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Bolt Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bolt Biotherapeutics' price. Additionally, you may evaluate how the addition of Bolt Biotherapeutics to your portfolios can decrease your overall portfolio volatility.